1,4-dihydropyridine has been researched along with Cardiovascular Diseases in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 6 (85.71) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Biccard, BM; Howell, SJ | 1 |
| Allen, AS; Chua, BS; Griffith, TF; Klassen, PS; Reddan, DN; Szczech, LA | 1 |
| Ferro, A; Welsh, L | 1 |
| Achard, JM; Choukroun, G; Fournier, A; Godefroy, O; Messerli, F; Modeliar, SS; Wang, J | 1 |
| Chobanian, AV | 1 |
| Halawa, B | 1 |
| Celis, H; Fagard, RH; Gasowski, J; Staessen, JA; Thijs, L; Wang, JG | 1 |
2 review(s) available for 1,4-dihydropyridine and Cardiovascular Diseases
| Article | Year |
|---|---|
Drug treatment of essential hypertension: the case for initial combination therapy.
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Cardiac Output; Cardiovascular Diseases; Dihydropyridines; Diuretics; Drug Therapy, Combination; Humans; Hypertension; Middle Aged; Renin-Angiotensin System; Sodium | 2004 |
[Calcium channel blockers in the treatment of cardiovascular disease].
Topics: Calcium Channel Blockers; Cardiovascular Diseases; Dihydropyridines; Humans | 2001 |
2 trial(s) available for 1,4-dihydropyridine and Cardiovascular Diseases
| Article | Year |
|---|---|
Does the MOSES trial establish superiority of AT1-receptor blockers over dihydropyridine/calcium antagonists in secondary stroke prevention?
Topics: Angiotensin II Type 1 Receptor Blockers; Apoptosis; Blood Pressure; Calcium; Cardiovascular Diseases; Dihydropyridines; Humans; Prevalence; Recurrence; Risk; Stroke; Time Factors; Treatment Outcome | 2006 |
Dihydropyridine calcium-channel blockers for antihypertensive treatment in older patients--evidence from the Systolic Hypertension in Europe Trial.
Topics: Aged; Alcohol Drinking; Calcium Channel Blockers; Cardiovascular Diseases; Dihydropyridines; Double-Blind Method; Europe; Female; Humans; Hypertension; Male; Middle Aged; Nitrendipine; Prognosis; Smoking; Treatment Outcome | 2001 |
3 other study(ies) available for 1,4-dihydropyridine and Cardiovascular Diseases
| Article | Year |
|---|---|
Calcium channel blockers, beta-blockers, and perioperative cardiovascular stability.
Topics: Adrenergic beta-Antagonists; Aortic Aneurysm; Calcium Channel Blockers; Cardiovascular Diseases; Dihydropyridines; Humans; Perioperative Care; Postoperative Complications | 2008 |
Characteristics of treated hypertension in incident hemodialysis and peritoneal dialysis patients.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Cardiovascular Diseases; Cause of Death; Cohort Studies; Comorbidity; Diabetes Mellitus; Dihydropyridines; Drug Prescriptions; Drug Utilization; Female; Humans; Hypertension; Kidney Failure, Chronic; Logistic Models; Lung Diseases; Male; Middle Aged; Peritoneal Dialysis; Prospective Studies; Renal Dialysis | 2003 |
Calcium channel blockers. Lessons learned from MIDAS and other clinical trials.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Arteriosclerosis; Calcium Channel Blockers; Cardiovascular Diseases; Clinical Trials as Topic; Confounding Factors, Epidemiologic; Dihydropyridines; Humans; Hypertension | 1996 |